BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 17409872)

  • 1. Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial.
    Flores RM; Krug LM; Rosenzweig KE; Venkatraman E; Vincent A; Heelan R; Akhurst T; Rusch VW
    J Thorac Oncol; 2006 May; 1(4):289-95. PubMed ID: 17409872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction chemotherapy, extrapleural pneumonectomy, and radiotherapy in the treatment of malignant pleural mesothelioma: the Memorial Sloan-Kettering experience.
    Flores RM
    Lung Cancer; 2005 Jul; 49 Suppl 1():S71-4. PubMed ID: 15950805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial).
    Hasegawa S; Okada M; Tanaka F; Yamanaka T; Soejima T; Kamikonya N; Tsujimura T; Fukuoka K; Yokoi K; Nakano T
    Int J Clin Oncol; 2016 Jun; 21(3):523-30. PubMed ID: 26577445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome for patients with malignant pleural mesothelioma referred for Trimodality therapy in Western Australia.
    Hasani A; Alvarez JM; Wyatt JM; Bydder S; Millward M; Byrne M; Musk AW; Nowak AK
    J Thorac Oncol; 2009 Aug; 4(8):1010-6. PubMed ID: 19546819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
    de Perrot M; Feld R; Cho BC; Bezjak A; Anraku M; Burkes R; Roberts H; Tsao MS; Leighl N; Keshavjee S; Johnston MR
    J Clin Oncol; 2009 Mar; 27(9):1413-8. PubMed ID: 19224855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): Feasibility and results.
    Rea F; Marulli G; Bortolotti L; Breda C; Favaretto AG; Loreggian L; Sartori F
    Lung Cancer; 2007 Jul; 57(1):89-95. PubMed ID: 17403553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
    Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
    Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma.
    Weder W; Stahel RA; Bernhard J; Bodis S; Vogt P; Ballabeni P; Lardinois D; Betticher D; Schmid R; Stupp R; Ris HB; Jermann M; Mingrone W; Roth AD; Spiliopoulos A;
    Ann Oncol; 2007 Jul; 18(7):1196-202. PubMed ID: 17429100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy.
    Thieke C; Nicolay NH; Sterzing F; Hoffmann H; Roeder F; Safi S; Debus J; Huber PE
    Radiat Oncol; 2015 Dec; 10():267. PubMed ID: 26715491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined modality treatment for malignant pleural mesothelioma: a single-centre long-term survival analysis using extrapleural pneumonectomy.
    Frick AE; Nackaerts K; Moons J; Lievens Y; Verbeken E; Lambrecht M; Coolen J; Dooms C; Vansteenkiste J; De Leyn P; Nafteux P
    Eur J Cardiothorac Surg; 2019 May; 55(5):934-941. PubMed ID: 30535191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma.
    Krug LM; Pass HI; Rusch VW; Kindler HL; Sugarbaker DJ; Rosenzweig KE; Flores R; Friedberg JS; Pisters K; Monberg M; Obasaju CK; Vogelzang NJ
    J Clin Oncol; 2009 Jun; 27(18):3007-13. PubMed ID: 19364962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy for malignant pleural mesothelioma: experience of Guy's and St Thomas' hospitals.
    Bille A; Belcher E; Raubenheimer H; Landau D; Cane P; Spicer J; Lang-Lazdunski L
    Gen Thorac Cardiovasc Surg; 2012 May; 60(5):289-96. PubMed ID: 22453539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma.
    Lang-Lazdunski L; Bille A; Lal R; Cane P; McLean E; Landau D; Steele J; Spicer J
    J Thorac Oncol; 2012 Apr; 7(4):737-43. PubMed ID: 22425923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A feasibility study evaluating Surgery for Mesothelioma After Radiation Therapy: the "SMART" approach for resectable malignant pleural mesothelioma.
    Cho BC; Feld R; Leighl N; Opitz I; Anraku M; Tsao MS; Hwang DM; Hope A; de Perrot M
    J Thorac Oncol; 2014 Mar; 9(3):397-402. PubMed ID: 24445595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of induction therapy on postoperative outcome after extrapleural pneumonectomy for malignant pleural mesothelioma: does induction-accelerated hemithoracic radiation increase the surgical risk?
    Mordant P; McRae K; Cho J; Keshavjee S; Waddell TK; Feld R; de Perrot M
    Eur J Cardiothorac Surg; 2016 Sep; 50(3):433-8. PubMed ID: 27005976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-recurrence chemotherapy for mesothelioma patients undergoing extrapleural pneumonectomy.
    Takuwa T; Hashimoto M; Matsumoto S; Kondo N; Kuribayash K; Nakano T; Hasegawa S
    Int J Clin Oncol; 2017 Oct; 22(5):857-864. PubMed ID: 28439676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma.
    Rice DC; Stevens CW; Correa AM; Vaporciyan AA; Tsao A; Forster KM; Walsh GL; Swisher SG; Hofstetter WL; Mehran RJ; Roth JA; Liao Z; Smythe WR
    Ann Thorac Surg; 2007 Nov; 84(5):1685-92; discussion 1692-3. PubMed ID: 17954086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of excision repair cross-complementation group 1 and ribonucleotide reductase M1 as prognostic biomarkers in malignant pleural mesothelioma treated with platinum-based induction chemotherapy followed by surgery.
    Frischknecht L; Meerang M; Soltermann A; Stahel R; Moch H; Seifert B; Weder W; Opitz I
    J Thorac Cardiovasc Surg; 2015 Jun; 149(6):1539-46.e1. PubMed ID: 25840756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma.
    de Perrot M; Feld R; Leighl NB; Hope A; Waddell TK; Keshavjee S; Cho BC
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):468-73. PubMed ID: 26614413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma.
    Weder W; Kestenholz P; Taverna C; Bodis S; Lardinois D; Jerman M; Stahel RA
    J Clin Oncol; 2004 Sep; 22(17):3451-7. PubMed ID: 15337794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.